Target Gene/Pathway💬 Info on mouse-over

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	AGE-RAGE signaling pathway in diabetic complications 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
2	AGE-RAGE signaling pathway in diabetic complications 💬	[2] VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
3	Bladder cancer 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
4	Bladder cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
5	Calcium signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
6	Calcium signaling pathway 💬	[2] VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
7	Collecting duct acid secretion 💬	[2] ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬
8	EGFR tyrosine kinase inhibitor resistance 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
9	EGFR tyrosine kinase inhibitor resistance 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
10	Fluid shear stress and atherosclerosis 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
11	Fluid shear stress and atherosclerosis 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
12	Focal adhesion 💬	[3] PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
13	Focal adhesion 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
14	Gastric acid secretion 💬	[2] ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬
15	HIF-1 signaling pathway 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
16	HIF-1 signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
17	Human cytomegalovirus infection 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
18	Human cytomegalovirus infection 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
19	Human papillomavirus infection 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
20	Human papillomavirus infection 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
21	Kaposi sarcoma-associated herpesvirus infection 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
22	Kaposi sarcoma-associated herpesvirus infection 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
23	MAPK signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
24	MAPK signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
25	Metabolic pathways 💬	[2] ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬
26	MicroRNAs in cancer 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
27	MicroRNAs in cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
28	Oxidative phosphorylation 💬	[2] ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬
29	Pancreatic cancer 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
30	Pancreatic cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
31	Pathways in cancer 💬	[3] PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
32	Pathways in cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
33	PI3K-Akt signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
34	PI3K-Akt signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
35	Proteoglycans in cancer 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
36	Proteoglycans in cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
37	Rap1 signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
38	Rap1 signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
39	Ras signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
40	Ras signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
41	Relaxin signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
42	Relaxin signaling pathway 💬	[2] VEGFA, VEGFB 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
43	Renal cell carcinoma 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
44	Renal cell carcinoma 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
45	Rheumatoid arthritis 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
46	Rheumatoid arthritis 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
47	VEGF signaling pathway 💬	[1] VEGFA 💬	D09574 💬	Aflibercept	[2] 90, 166 💬
48	VEGF signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬

Back to top